Are treatment outcomes of patients with tuberculosis detected by active case finding different from those detected by passive case finding?

• Main Authors: Mahendra Singh, Karuna D Sagili, Jaya P Tripathy, Surekha Kishore, Yogesh A Bahurupi, Ajay Kumar, Vagish Kala, Vikas Yadav, Shikha Murmu
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2020-01-01
• Series: Journal of Global Infectious Diseases
• Subjects: case finding; india; loss to follow-up; operational research; stigma; treatment outcome; tuberculosis
• Online Access: http://www.jgid.org/article.asp?issn=0974-777X;year=2020;volume=12;issue=1;spage=28;epage=33;aulast=Singh

Context: India has adopted active case finding (ACF) as an additional strategy to find its missing tuberculosis (TB) cases since 2017. Treatment outcomes of patients identified through ACF may be similar or different from those detected through routine passive case finding (PCF); currently, there are limited studies on this in India. Aim: The aim of this study was to assess differences in treatment outcomes of patients detected through ACF and PCF under the national TB program. Study Design: A study was conducted in six TB units of Haridwar district where ACF campaigns were conducted in 2017–2018. Methods: Data from patients detected by ACF (n = 72) and PCF (n = 184) were extracted from program records. Results: Of 72 patients detected by ACF, only 54 (75%) were initiated on treatment. A high proportion of initial loss to follow-up (25% vs. 0%) and delay in treatment initiation (4 days vs. 0 days) was observed in ACF patients as compared to PCF. The proportion of unsuccessful treatment outcome was 33% (n = 18) among ACF patients compared to 14% (n = 25) among PCF patients (adjusted relative risk: 2.6, 95% confidence interval: 1.7–4.0). Conclusion: High initial loss to follow-up, delay in treatment initiation, and poor treatment outcome among ACF patients are a major concern. The study results call for active follow-up after diagnosis and close monitoring during treatment for patients detected by ACF.